SEMMELWEIS UNIVERSITY, CENTRE FOR TRANSLATIONAL MEDICINE

TOPIC

The Biotechnological Improvements of Clinical Hemato-oncology

VISION

Provide new therapeutic solutions in hemato-oncology.

MISSION

Show the big picture of our current knowledge about a novel therapeutic option’s (CAR T cells) utility in clinical level.

SPECIFIC GOALS
  • PROJECT 1: Comparing efficacy and toxicity of CAR T-cell versus conventional therapy in hemato-oncology: a systematic review and meta-analysis.
  • PROJECT 2: Long-term effects of CAR T-cell treatment in hematological malignancies: a systematic review and meta-analysis.

Progress Reports